Navigation Links
Better Drug for Heart Transplant

A new study shows the drug everolimus is better at reducing problems in heart transplant patients than one of the currently used drugs. Specifically the drug reduced the incidence of a serious disorder that can cause deterioration of the graft known as coronary vasculopathy.//

Previous studies have shown everolimus combined with another drug reduced the rejection and risk of infection in kidney transplant patients. Researchers from Temple University in Philadelphia conducted a study to determine if everolimus is also effective for heart transplant patients.

For the study, 634 patients were randomly assigned to receive one of two doses of everolimus or another drug, azathioprine, after having a heart transplant. The drugs were given once a day in combination with other standard treatments. Researchers followed patients for one year to determine if they had any complications from the transplant.

Researchers report the patients on either dose of everolimus fared much better than the patients on azathioprine. After one year, researchers say it was clear everolimus was significantly more effective than azathioprine in preventing vasculopathy. Study authors write, "Everolimus combined with cyclosporine and corticosteroids during the first 12 months is a safe and effective immunosuppressant regimen for use in recipients of a first heart transplant."

Researchers say further evaluation and follow-up are needed to determine the optimal dose. However, they say the findings of this study offer some optimism that everolimus is a promising agent for the management of rejection and vasculopathy after heart transplantation.
'"/>




Page: 1

Related medicine news :

1. Better prostate cancer detection
2. Better Treatment for obesity
3. For a Better Memory
4. Baby Talk Better Than Adult Speech
5. Drug Combo Works Better for children with ADHD, Tics
6. Better skin with lasers
7. Better diabetes treatment promises Vanadium
8. Better Prostate Cancer Test
9. Better Diet Even Late in Life May Prolong It
10. Better Care Required for Breast Cancer Survivors
11. Two drugs Mays Be Better Than One For Prostate Enlargement
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... ... Planet Fitness, one of the largest and fastest growing franchisors and operators ... location in Covington, LA at 401 N. U.S. Highway 190, in January of 2018. ... in the Holiday Square shopping center. Its location allows it to serve both Covington ...
(Date:10/12/2017)... ... 12, 2017 , ... The American College of Medical Informatics (ACMI) will present ... the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium ... Collen, a pioneer in the field of medical informatics, this prestigious award is presented ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... Restoration, has recently contributed a medical article to the newly revamped Cosmetic ... Mohebi’s article spotlights the hair transplant procedure known as Follicular Unit Extraction ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the Health & ... by Moonlight to raise money for the American Heart Association Heart Walk. Teams of ... will work together to keep their treadmills moving for 5 hours. Treadmills will start ...
(Date:10/12/2017)... BALTIMORE (PRWEB) , ... October 12, 2017 , ... ... average of $3,296 in property taxes a year. In some states—like New York, ... higher. , By contrast, many overseas retirement havens have extremely low property-tax rates, ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion ... notable awards. Ranked as number one in the South Florida ... time in Inc. 5000 yearly list, the national specialty pharmacy ... Armando Bardisa will soon be honored by SFBJ ... Set to receive his award in ...
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
Breaking Medicine Technology: